Menus Subscribe Search

Follow us


Three Not So Blind Mice: The Future Looks Bright

• November 19, 2012 • 11:35 AM

The three blind mice might not have to stay that way much longer. British scientists have shown for the first time that they can improve vision in rodents—by transplanting light-sensitive cells into their eyes.

The research could lead to new treatments for millions of people suffering from common forms of blindness, such as retinitis pigmentosa and age-related macular degeneration, says Rachael Pearson, a Royal Society Research Fellow at University College London.The achievement was hailed by biologist Stephen Rose, chief research officer of the Foundation Fighting Blindness, a private nonprofit that raises money for inherited-retinal-disease research. “We are very happy with it,” he says. “We believe that it’s extremely good work.”

In a paper published on earlier this year in Nature, Pearson and her colleagues describe how they injected immature rods—the cells responsible for peripheral vision and the ability to see at night—into the eyes of mice that had been bred without functioning rods.

In these night-blind mice, the thousands of newly transplanted cells linked up with existing nerve cells in the retina, the layer of light-sensitive tissue in the back of the eye. The researchers had previously proved that transplantation could work; this time they greatly increased the number of transferred cells, boosting the number of apparently functional rod cells 20- to 30-fold. Then, they looked for evidence that the mice actually had better night vision.

Pearson and her team examined the transplanted cells to see whether they responded to light. They also measured electrical activity in the visual cortex of the mice, tracked the mice’s head movements to see whether they would react to patterns on a screen, and plopped them in a water tank to see if they’d swim toward a less than obvious exit. Despite the dim light, the transplanted mice were able to find their way out. “The mice who didn’t have the transplant swam around in circles,” Pearson says. “These mice can’t see in dim light, and so they can’t use any visual cues to escape.”

The trick to getting transplanted rods to function, Pearson says, is to harvest cells that are at just the right stage of development from donor mice. In people, it soon may be possible to cultivate a patient’s own stem cells and turn them into rods and cones. Meanwhile, Pearson and her colleagues are still trying to perfect the process of transplanting cones. “We demonstrated proof of principle a couple of years ago, but currently the numbers we can get to integrate are much lower than with the rods,” she says.

Age-related macular degeneration, the leading cause of blindness in people over 50, gradually damages the macula, the part of the retina responsible for central vision. A National Institutes of Health study estimates that nearly three million Americans will be affected by 2020. An additional 100,000 people in the U.S. suffer from retinitis pigmentosa, a group of inherited diseases that cause the retina to deteriorate.

Successful animal research doesn’t always translate into an effective treatment for humans, Rose cautions. “These are very carefully done studies, very well conducted,” he says. “There’s no reason to believe, from what I’ve seen, that it couldn’t work. But the proof of the pudding is the eating thereof.”

Michael Haederle
Michael Haederle lives in New Mexico. He has written for the Los Angeles Times, People Magazine, Tricycle: The Buddhist Review and many other publications. He has also taught at Syracuse University's S.I. Newhouse School of Public Communications and is a Zen lay monk.

More From Michael Haederle

A weekly roundup of the best of Pacific Standard and PSmag.com, delivered straight to your inbox.

Recent Posts

October 31 • 4:00 AM

The Power of Third Person Plural on Support for Public Policies

Researchers find citizens react differently to policy proposals when they’re framed as impacting “people,” as opposed to “you.”


October 30 • 4:00 PM

I Should Have Told My High School Students About My Struggle With Drinking

As a teacher, my students confided in me about many harrowing aspects of their lives. I never crossed the line and shared my biggest problem with them—but now I wish I had.


October 30 • 2:00 PM

How Dark Money Got a Mining Company Everything It Wanted

An accidentally released court filing reveals how one company secretly gave money to a non-profit that helped get favorable mining legislation passed.


October 30 • 12:00 PM

The Halloween Industrial Complex

The scariest thing about Halloween might be just how seriously we take it. For this week’s holiday, Americans of all ages will spend more than $5 billion on disposable costumes and bite-size candy.


October 30 • 10:00 AM

Sky’s the Limit: The Case for Selling Air Rights

Lower taxes and debt, increased revenue for the city, and a much better use of space in already dense environments: Selling air rights and encouraging upward growth seem like no-brainers, but NIMBY resistance and philosophical barriers remain.


October 30 • 9:00 AM

Cycles of Fear and Bias in the Criminal Justice System

Exploring the psychological roots of racial disparity in U.S. prisons.


October 30 • 8:00 AM

How Do You Make a Living, Email Newsletter Writer?

Noah Davis talks to Wait But Why writer Tim Urban about the newsletter concept, the research process, and escaping “money-flushing toilet” status.



October 30 • 6:00 AM

Dreamers of the Carbon-Free Dream

Can California go full-renewable?


October 30 • 5:08 AM

We’re Not So Great at Rejecting Each Other

And it’s probably something we should work on.


October 30 • 4:00 AM

He’s Definitely a Liberal—Just Check Out His Brain Scan

New research finds political ideology can be easily determined by examining how one’s brain reacts to disgusting images.


October 29 • 4:00 PM

Should We Prosecute Climate Change Protesters Who Break the Law?

A conversation with Bristol County, Massachusetts, District Attorney Sam Sutter, who dropped steep charges against two climate change protesters.


October 29 • 2:23 PM

Innovation Geography: The Beginning of the End for Silicon Valley

Will a lack of affordable housing hinder the growth of creative start-ups?


October 29 • 2:00 PM

Trapped in the Tobacco Debt Trap

A refinance of Niagara County, New York’s tobacco bonds was good news—but for investors, not taxpayers.


October 29 • 12:00 PM

Purity and Self-Mutilation in Thailand

During the nine-day Phuket Vegetarian Festival, a group of chosen ones known as the mah song torture themselves in order to redirect bad luck and misfortune away from their communities and ensure a year of prosperity.


October 29 • 10:00 AM

Can Proposition 47 Solve California’s Problem With Mass Incarceration?

Reducing penalties for low-level felonies could be the next step in rolling back draconian sentencing laws and addressing the criminal justice system’s long legacy of racism.


October 29 • 9:00 AM

Chronic Fatigue Syndrome and the Brain

Neuroscientists find less—but potentially stronger—white matter in the brains of patients with CFS.


October 29 • 8:00 AM

America’s Bathrooms Are a Total Failure

No matter which American bathroom is crowned in this year’s America’s Best Restroom contest, it will still have a host of terrible flaws.



October 29 • 6:00 AM

Tell Us What You Really Think

In politics, are we always just looking out for No. 1?


October 29 • 4:00 AM

Racial Resentment Drives Tea Party Membership

New research finds a strong link between tea party membership and anti-black feelings.


October 28 • 4:00 PM

The New Health App on Apple’s iOS 8 Is Literally Dangerous

Design isn’t neutral. Design is a picture of inequality, of systems of power, and domination both subtle and not. Apple should know that.


October 28 • 2:00 PM

And You Thought Your Credit Card Debt Was Bad

In Niagara County, New York, leaders took on 40-year debt to pay for short-term stuff, a case study in the perverse incentives tobacco bonds create.



October 28 • 10:00 AM

How Valuable Is It to Cure a Disease?

It depends on the disease—for some, breast cancer and AIDS for example, non-curative therapy that can extend life a little or a lot is considered invaluable. For hepatitis C, it seems that society and the insurance industry have decided that curative therapy simply costs too much.


Follow us


We’re Not So Great at Rejecting Each Other

And it's probably something we should work on.

Chronic Fatigue Syndrome and the Brain

Neuroscientists find less—but potentially stronger—white matter in the brains of patients with CFS.

Incumbents, Pray for Rain

Come next Tuesday, rain could push voters toward safer, more predictable candidates.

Could Economics Benefit From Computer Science Thinking?

Computational complexity could offer new insight into old ideas in biology and, yes, even the dismal science.

Politicians Really Aren’t Better Decision Makers

Politicians took part in a classic choice experiment but failed to do better than the rest of us.

The Big One

One town, Champlain, New York, was the source of nearly half the scams targeting small businesses in the United States last year. November/December 2014

Copyright © 2014 by Pacific Standard and The Miller-McCune Center for Research, Media, and Public Policy. All Rights Reserved.